1EST Lead Informatics, AstraZeneca R&D Mölndal, S-43183, Mölndal, Sweden. tudor.oprea@astrazeneca.com
Despite increased compound testing, new chemical entity discovery remains stagnant. Novel methods like neighborhood behavior and chemical property navigation are crucial for advancing lead discovery and optimizing pharmacokinetic properties in drug development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: